Durable Clinical Response to Pyrotinib After Resistance to Prior Anti-HER2 Therapy for HER2-Positive Advanced Gastric Cancer: A Case Report.

Huang, Le-Tian; Ma, Jie-Tao; Zhang, Shu-Ling; Li, Xiao-Han; Sun, Li; Jing, Wei; Zhao, Jian-Zhu; Wang, Yan-Ru; Han, Cheng-Bo.

Afiliação

Huang LT; Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, China.
Ma JT; Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, China.
Zhang SL; Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, China.
Li XH; Department of Pathology, Shengjing Hospital of China Medical University, Shenyang, China.
Sun L; Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, China.
Jing W; Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, China.
Zhao JZ; Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, China.
Wang YR; Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, China.
Han CB; Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, China.